Patents for A61P 23 - Anaesthetics (4,141)
07/2004
07/15/2004US20040136914 Buccal, polar and non-polar spray containing ondansetron
07/14/2004EP1436327A1 Ee3-protein family and corresponding dna sequences
07/14/2004EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
07/14/2004CN1512900A Aerosol forming device for use in inhalation therapy
07/08/2004US20040133012 For use as anesthetics and as neuroprotective agents; prevents the formation of the toxic metabolite, 2-phenyl-acrylamide
07/08/2004US20040132757 Triazospiro compounds having nociceptin receptor affinity
07/07/2004EP1235827B1 Imidazo-pyridine derivatives as ligands for gaba receptors
07/01/2004WO2004041241A3 Implantable structure for prolonged and controlled release of an active principle
06/2004
06/30/2004EP1432424A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions
06/30/2004EP1432419A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers
06/30/2004CN1507918A Transdermal promotor glycerin triacetate
06/30/2004CN1155372C Electrically assisted delivery conveyor and using method thereof
06/29/2004US6756053 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source
06/24/2004WO2004052399A1 Composition for topical anesthesia
06/24/2004WO2004052354A1 Propofol-containing fat emulsions
06/24/2004WO2004052337A2 Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient
06/24/2004CA2508441A1 Propofol-containing fat emulsions
06/23/2004EP1430017A2 Substituted phenol compounds useful for anesthesia and sedation
06/23/2004EP0999839B1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
06/22/2004US6753335 Delta agonists for nervous system pain
06/17/2004WO2004010941A3 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
06/17/2004WO2003063824A3 Pharmaceutical composition
06/16/2004EP1315731B1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/16/2004EP1294364A4 Stable gabapentin having ph within a controlled range
06/10/2004WO2004048332A1 Isoindoline derivative
06/10/2004WO2004047819A2 Composition and its use for treating neuropathic sensory loss
06/09/2004EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
06/09/2004CN1152674C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
06/03/2004US20040106576 Derivatives of venlafaxine and methods of preparing and using the same
06/02/2004EP1424067A1 Injectable foam and novel pharmaceutical applications thereof
06/01/2004US6743949 Process of obtainment of racemic cetamine enantiomers; process of obtainment of pharmaceutically acceptable salts from racemic cetamine enantiomes and use of pharmaceutically acceptable salts obtained by means of said mentioned process
06/01/2004US6743436 Anesthetic composition for intravenous injection comprising propofol
05/2004
05/27/2004WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes
05/27/2004US20040101833 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and riluzole
05/26/2004EP1422217A2 Aminocyclohexyl ether compounds and uses thereof
05/26/2004EP1420645A1 Multivesicular emulsion topical delivery systems
05/26/2004EP1299095B1 Clear aqueous anaesthetic composition
05/26/2004EP1161226B1 Phosphocholine linked prodrug derivatives
05/25/2004US6740306 Imidazotriazinone-containing compositions for nasal administration
05/21/2004WO2004041269A2 New use for pharmaceutical composition
05/21/2004WO2004041241A2 Implantable structure for prolonged and controlled release of an active principle
05/21/2004CA2504802A1 Pharmaceutical composition comprising cannabinoids for the treatment of pain and sleep disorders
05/21/2004CA2504479A1 Implantable structure for prolonged and controlled release of an active principle
05/20/2004US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
05/20/2004US20040097569 Aryl substituted hydantoin compounds and their use as sodium channel blockers
05/20/2004US20040097539 Hsp inductor
05/20/2004US20040096402 Mixing a vapor, formed by heating a compound on a substrate, with a gas, in a ratio to form an aerosol with a mass median aerodynamic diameter of less than 1 mu m when a stable number concentration of particles in the gas is reached.
05/19/2004EP1420020A1 4-oxoimidazolidine-2-spiropiperidine derivative
05/19/2004EP1418891A1 Anaesthetic formulations of propofol
05/19/2004EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
05/19/2004EP1299287A4 Methods of producing a terminally sterilized topical patch preparation
05/19/2004EP1265618A4 Anaesthetic composition
05/19/2004CN1498115A Hydroxyalkyl starch-active agent-conjugate
05/19/2004CN1498104A Novel application of peptide class of compound for treating allodynia or other different types of chronic or phantom pain
05/19/2004CN1149984C Anesthetic compsn. for intravenous injection comprising propofol
05/18/2004US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/13/2004US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal
05/12/2004EP1417187A1 Aryl substituted thiazolidinones and the use thereof
05/12/2004EP1416842A2 Pharmaceutical combinations of oxycodone and naloxone
05/12/2004CN1149080C Prilocaine and hydrofluorocarbon aerosol preparations
05/12/2004CN1149072C New pharmaceutical composition with anaesthetic effect
05/11/2004US6734176 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
05/11/2004CA2352597C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
05/06/2004WO2004037750A2 Short-acting sedative hypnotic agents for anesthesia and sedation
05/06/2004WO2004010950A3 Aryl substituted hydantoin compounds and their use as sodium channel blockers
05/06/2004WO2003105779A3 Guanidine compounds as anesthetics and for treatment of nervous system disorders
05/06/2004US20040087598 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives
05/06/2004EP1227714B1 Method for producing metabolites from plants cultivated in soil-less medium
05/06/2004EP1009390A4 Prolonged anesthesia in joints and body spaces
04/2004
04/28/2004EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
04/28/2004EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives
04/28/2004CN1147470C Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicine
04/28/2004CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
04/27/2004US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics
04/27/2004US6726919 For inducing or maintaining anesthesia or sedation in a patient
04/27/2004CA2271750C Prolonged anesthesia in joints and body spaces
04/22/2004WO2004032907A1 Painlessly removable transdermal medical patch
04/22/2004US20040076648 Antidepressant, an n-methyl-aspartic acid receptor antagonist, a lipophilic component, water and a surfacant; oil in water emulsion
04/22/2004DE10153346A1 Substituierte Indole Substituted indoles
04/21/2004CN1146410C Controlled release formulation
04/15/2004US20040072792 Local anesthetic and agent for maintaining anesthetic action; acidic mucopolysaccharide or a cellulose derivative; does not contain a catecholamine; for oral surgery or dental treatment; sodium chondroitin sulfate; hydroxypropylmethylcellulose
04/14/2004EP1406888A1 Substituted $g(g)-lactone compounds serving as nmda antagonists
04/14/2004EP1406858A1 Substituted 4-aminocyclohexanols
04/14/2004CN1489457A Clear and stable propofol composition
04/14/2004CN1145483C Levobupivacaine and its use as an anaesthetic in pregnant women
04/08/2004US20040068007 Diclofenac salt of lidocaine
04/08/2004US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
04/08/2004DE10245212A1 Säurehaltige Desensibilisierungsmittel für Zähne Acidic desensitizing agent for teeth
04/07/2004EP1405646A2 Pharmaceutically acceptable salts of local anaesthetics with anti-inflammatory compounds and methods for preparing the same
04/07/2004CN1486690A Medicinal salt with local narcosis and antiphlogosis activity and its prepn process
04/01/2004US20040063747 Local anesthetic methods and kits
04/01/2004US20040062743 Mixture with film forming polymer
04/01/2004US20040062724 Thin, flexible, multilayer film; applying, adhesion to teeth; supplying active materials
03/2004
03/31/2004EP1402882A1 Acid-containing tooth desensitising material
03/31/2004EP1401841A1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
03/31/2004EP1401408A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
03/31/2004CN1143688C Triacetin as transdermal permeation enhancer
03/31/2004CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
03/25/2004WO2003068200A3 Novel therapeutic application for a composition
03/25/2004US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 42